From: "Dr. D. Kossove" <doctordee@telkomsa.net>
To: "lmS List"; "acc List"
Subject: CONTACTS for clinical trial phase 1 with genasense, the bcl-2 inhibitor
Date: Thursday, January 22, 2004 1:50 PM

Ph I trial: Genasense combined with Carbopltin and Paclitaxil
 
Glenn Liu, M.D.
U os Wisconsin Hosp and Clinic; K6/5
600 Highland Avenue
Madison, Wisconsin  53792
608 265 8131
gxl@medicine.wisc.edu
 
 
PhI trial: Genasense combined with GEMZAR
 
Branimir Sikic, M.D.
Stanford U School of Medicine
269 Campus Dr. CCSR N 1105
Stanford, CA.   94305 5115
605 723 5290
brandy@stanford.edu
 
 